Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01702571
Brief Title: A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

First Submitted : October 4, 2012
First Submitted that Met QC Criteria : October 4, 2012
First Posted : October 8, 2012 (Estimate)

Results First Submitted : July 14, 2021
Results First Submitted that Met QC Criteria : July 14, 2021
Results First Posted : August 5, 2021

Last Update Submitted that Met QC Criteria : July 14, 2021
Last Update Posted : August 5, 2021